Pacidamycins, a novel series of antibiotics with anti-pseudomonas aeruginosa activity: III. Microbiologic profile

The Journal of Antibiotics

Volumn 42, Issue 4, 1989, Pages 521-526

  Fernandes, Prabhavathi B ^a   Swanson, Robert N ^a   Hardy, Dwight J ^a   Hanson, Charles W ^a   Coen, Lyle ^a   Rasmussen, Ronald R ^a   Chen, Randal H ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; PACIDAMYCIN; PACIDAMYCIN 1; PACIDAMYCIN 2; PACIDAMYCIN 3; PACIDAMYCIN 5; PIPERACILLIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELL CULTURE; DRUG HALF LIFE; DRUG RESISTANCE; DRUG SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOUSE; MUTANT; NONHUMAN; ORAL DRUG ADMINISTRATION; PH; PRIORITY JOURNAL; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; SERUM; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMAL; ANTIBIOTICS; BACTERIA; DRUG RESISTANCE, MICROBIAL; FEMALE; HALF-LIFE; HUMAN; HYDROGEN-ION CONCENTRATION; KINETICS; MICE; MICROBIAL SENSITIVITY TESTS; OLIGOPEPTIDES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PYRIMIDINE NUCLEOSIDES;

EID: 0024509967     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.7164/antibiotics.42.521     Document Type: Article

References (7)

1. Milatovic, D. & I. Braveny: Development of resistance during antibiotic therapy. Eur. J. Clin. Microbiol. 6: 234~244, 1987.
2. Karwowski, J.P.; M. Jackson, R.J. Theriault, R. H. Chen, G. J. Barlow & M. L. Maus: Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. I. Taxonomyof the producing organism and fermentation. J. Antibiotics 42: 506~511, 1989.
3. Chen, R. H.; A. M. Buko, D.N. Whittern & J.B. McAlpine: Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. II. Isolation and structural elucidation. J. Antibiotics 42: 512~520, 1989.
4. Swanson, R.N.; D.J. Hardy, C.W. Hanson, L. Coen, D. Hensey, R.H. Chen, J.B. McAlpine & P. B. Fernandes: Pacidamycins, a novel series of antibiotics with Pseudomonasaeruginosa activity. II. Structural determination and microbiological profile. Program and Abstracts of the 28th Intersci. Conf. on Antimicrob. Agents Chemother., No. 310, p. 164, Los Angeles, Oct. 23~26, 1988.
5. National Committee for Clinical Laboratory Standards : Standards Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria which Grow Aerobically. Approved Standard M7-A. National Committee for Clinical Laboratory Standards, Villanova, 1985.
6. Fernandes, P. B.; R. Bailer, R. Swanson, C. W. Hanson, E. McDonald, N. Ramer, D. Hardy, N. Shipkowitz, R. R. Bower & E. Gade: In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide. Antimicrob. Agents Chemother. 30: 865~873, 1986.
7. Fernandes, P.B.; C. W. Hanson, J. M. Stamm, C. Vojtko, N. L. Shipkowitz & E. S. Martin: The frequency of in vitro resistance development to fluoroquinolones and the use of a murine pyelonephritis model to demonstrate selection of resistance in vivo, J. Antimicrob. Chemother. 19 : 449~466, 1987.